Search research articles
Contact Us
Filters
Showing results (1-10 of 130) with videos related to
Page
of 13
Sort By:
Archivos De Bronconeumologia
|
June 30, 2019
The Future of Pharmacological Treatment in Idiopathic Pulmonary Fibrosis
Maria Molina-Molina
The Lancet. Respiratory Medicine
|
November 3, 2024
The challenge of therapeutic options for patients with lymphangioleiomyomatosis
Maria Molina-Molina
American Journal of Respiratory and Critical Care Medicine
|
January 10, 2019
Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
Maria Molina-Molina
The European Respiratory Journal
|
May 25, 2023
The relationship between gastro-oesophageal reflux and pulmonary fibrosis: a never-ending story
Maria Molina-Molina
Current Opinion in Pulmonary Medicine
|
August 2, 2018
Clinical implications of telomere dysfunction in lung fibrosis
Maria Molina-Molina, Raphael Borie
Breathe (Sheffield, England)
|
March 21, 2020
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
Guillermo Suarez-Cuartin, Maria Molina-Molina
Annals of Global Health
|
February 12, 2019
Interstitial Lung Diseases in Developing Countries
Pilar Rivera-Ortega, Maria Molina-Molina
Respiration; International Review of Thoracic Diseases
|
October 14, 2015
Treatment Considerations of Lung Involvement in Rheumatologic Disease
Alejandro Robles-Perez, Maria Molina-Molina
Breathe (Sheffield, England)
|
June 14, 2019
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
Guillermo Suarez-Cuartin, Maria Molina-Molina
Archivos De Bronconeumologia
|
November 1, 2022
Highlights for the Clinical Practice in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: From the ATS/ERS/ALAT/JRS 2022 Guideline
Vanesa Vicens-Zygmunt, Maria Molina-Molina, Ganesh Raghu
Page
of 13
Search research articles
Search
Showing results (1-10 of 130) with videos related to
Sort By:
Page
of 13
Archivos De Bronconeumologia
|
June 30, 2019
The Future of Pharmacological Treatment in Idiopathic Pulmonary Fibrosis
Maria Molina-Molina
The Lancet. Respiratory Medicine
|
November 3, 2024
The challenge of therapeutic options for patients with lymphangioleiomyomatosis
Maria Molina-Molina
American Journal of Respiratory and Critical Care Medicine
|
January 10, 2019
Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
Maria Molina-Molina
The European Respiratory Journal
|
May 25, 2023
The relationship between gastro-oesophageal reflux and pulmonary fibrosis: a never-ending story
Maria Molina-Molina
Current Opinion in Pulmonary Medicine
|
August 2, 2018
Clinical implications of telomere dysfunction in lung fibrosis
Maria Molina-Molina, Raphael Borie
Breathe (Sheffield, England)
|
March 21, 2020
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
Guillermo Suarez-Cuartin, Maria Molina-Molina
Annals of Global Health
|
February 12, 2019
Interstitial Lung Diseases in Developing Countries
Pilar Rivera-Ortega, Maria Molina-Molina
Respiration; International Review of Thoracic Diseases
|
October 14, 2015
Treatment Considerations of Lung Involvement in Rheumatologic Disease
Alejandro Robles-Perez, Maria Molina-Molina
Breathe (Sheffield, England)
|
June 14, 2019
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
Guillermo Suarez-Cuartin, Maria Molina-Molina
Archivos De Bronconeumologia
|
November 1, 2022
Highlights for the Clinical Practice in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: From the ATS/ERS/ALAT/JRS 2022 Guideline
Vanesa Vicens-Zygmunt, Maria Molina-Molina, Ganesh Raghu
Page
of 13